PURPOSE OF REVIEW: Due to medical advances and an aging population, the number of cancer survivors continues to rise. Survivors often experience late and long-term sequelae of cancer and its treatment (e.g., fatigue, pain, fear of recurrence, and stress). As a result, some patients have utilized or expressed interest in integrative medicine (IM) modalities for prevention of recurrence, optimizing health, enhancing quality of life, and managing symptoms. The purpose of this review is to focus on research published during the past year that informs our understanding of the utility of IM for cancer survivors. RECENT FINDINGS: Physical activity, diet, dietary supplements, mind-body modalities, acupuncture, and massage therapy all may play a role in the management of the physical (e.g., fatigue and pain) and emotional (e.g., anxiety and fear) issues faced by cancer survivors. SUMMARY: IM therapies are appealing to and utilized by many cancer survivors and may reduce symptom burden. Clinicians who provide cancer survivorship care may improve patient care by understanding the evidence for and against their use.
PURPOSE OF REVIEW: Due to medical advances and an aging population, the number of cancer survivors continues to rise. Survivors often experience late and long-term sequelae of cancer and its treatment (e.g., fatigue, pain, fear of recurrence, and stress). As a result, some patients have utilized or expressed interest in integrative medicine (IM) modalities for prevention of recurrence, optimizing health, enhancing quality of life, and managing symptoms. The purpose of this review is to focus on research published during the past year that informs our understanding of the utility of IM for cancer survivors. RECENT FINDINGS: Physical activity, diet, dietary supplements, mind-body modalities, acupuncture, and massage therapy all may play a role in the management of the physical (e.g., fatigue and pain) and emotional (e.g., anxiety and fear) issues faced by cancer survivors. SUMMARY: IM therapies are appealing to and utilized by many cancer survivors and may reduce symptom burden. Clinicians who provide cancer survivorship care may improve patient care by understanding the evidence for and against their use.
Authors: A D Hagstrom; P W M Marshall; C Lonsdale; B S Cheema; M A Fiatarone Singh; S Green Journal: Eur J Cancer Care (Engl) Date: 2015-11-23 Impact factor: 2.520
Authors: Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler Journal: CA Cancer J Clin Date: 2012-04-26 Impact factor: 508.702
Authors: Lawrence H Kushi; Colleen Doyle; Marji McCullough; Cheryl L Rock; Wendy Demark-Wahnefried; Elisa V Bandera; Susan Gapstur; Alpa V Patel; Kimberly Andrews; Ted Gansler Journal: CA Cancer J Clin Date: 2012 Jan-Feb Impact factor: 508.702
Authors: Suzanna Maria Zick; Justin Colacino; Maria Cornellier; Tohfa Khabir; Katie Surnow; Zora Djuric Journal: Breast Cancer Res Treat Date: 2016-12-02 Impact factor: 4.872
Authors: Eila Watson; Bethany Shinkins; Emma Frith; David Neal; Freddie Hamdy; Fiona Walter; David Weller; Clare Wilkinson; Sara Faithfull; Jane Wolstenholme; Prasanna Sooriakumaran; Christof Kastner; Christine Campbell; Richard Neal; Hugh Butcher; Mike Matthews; Rafael Perera; Peter Rose Journal: BJU Int Date: 2015-05-23 Impact factor: 5.588
Authors: Eline H van Roekel; Martijn J L Bours; José J L Breedveld-Peters; Paul J B Willems; Kenneth Meijer; Ijmert Kant; Piet A van den Brandt; Geerard L Beets; Silvia Sanduleanu; Matty P Weijenberg Journal: Cancer Causes Control Date: 2016-02-18 Impact factor: 2.506
Authors: Shruti R Patel; Jacqueline Zayas; Jose R Medina-Inojosa; Charles Loprinzi; Elizabeth J Cathcart-Rake; Anjali Bhagra; Janet E Olson; Fergus J Couch; Kathryn J Ruddy Journal: Glob Adv Health Med Date: 2021-01-08
Authors: Lorenzo Lippi; Alessandro de Sire; Luigi Losco; Kamal Mezian; Arianna Folli; Mariia Ivanova; Lorenzo Zattoni; Stefano Moalli; Antonio Ammendolia; Carmine Alfano; Nicola Fusco; Marco Invernizzi Journal: J Clin Med Date: 2022-07-01 Impact factor: 4.964